CVS Health Corp vs Deckers Outdoor Corp — how do they compare? CVS Health Corp trades at $86.93 (market cap $112.29B), while Deckers Outdoor Corp trades at $83.14 (market cap $11.24B). The key difference: CVS Health Corp is far larger — about 10× Deckers Outdoor Corp's market cap, and CVS Health Corp pays a 3.03% dividend while Deckers Outdoor Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Deckers Outdoor Corp for 71 Days on average.
| CVS | DECK | |
|---|---|---|
Market Cap | $112.29B | $11.24B |
Volume | 7,763,676 | 3,010,945 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $120.94 |
52-Week Low | $70.08 | $77.51 |
Typical Hold Time | 83 Days | 71 Days |
Enterprise Value | $174.64B | $10.11B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.12, down 0.94% on the day, with strong analyst support showing 85% buy ratings and a $111.20 consensus price target. The stock demonstrates solid revenue growth, reaching $402.07 billion in 2025, though net margins compressed to 1.18%. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 forecast. Technical indicators show a bearish trend with key support at $85.
CVS presents a compelling value opportunity with attractive valuation ratios (P/E 23.17, P/S 0.27) and consistent dividend payments. However, declining profit margins and ongoing regulatory scrutiny pose risks. The company's Medicare expansion and healthcare services growth provide upside potential, but investors should monitor reimbursement pressures and competitive dynamics in the evolving healthcare landscape.
Deckers Outdoor (DECK) trades at $83.32, up 3.66% with strong momentum as technical indicators show bullish signals. The company demonstrates robust fundamentals with revenue growing from $3.2B in 2022 to $5.0B in 2025, net profit margin expanding to 19.37%, and attractive valuation metrics including P/E of 11.74. Recent earnings beats and strong HOKA/UGG brand performance support positive sentiment.
Outlook remains positive with 44.65% analyst buy ratings and $117.13 consensus price target suggesting 40% upside potential. Key risks include competitive pressures in footwear sector and potential consumer spending slowdown. The stock presents a compelling growth opportunity with strong cash flow generation and expanding margins.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →